tiprankstipranks
Organovo Holdings (ONVO)
NASDAQ:ONVO

Organovo Holdings (ONVO) Stock Price & Analysis

1,523 Followers

ONVO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.89 - $2.33
Previous Close$1.05
Volume235.91K
Average Volume (3M)130.26K
Market Cap
$9.94M
Enterprise Value$3.94M
Total Cash (Recent Filing)$7.60M
Total Debt (Recent Filing)$1.60M
Price to Earnings (P/E)-0.5
Beta1.63
Aug 08, 2019
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)-2.17
Shares Outstanding10,040,074
10 Day Avg. Volume57,895
30 Day Avg. Volume130,257
Standard Deviation0.22
R-Squared0.05
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)1.18
Price to Sales (P/S)28.49
Price to Cash Flow (P/CF)-0.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue10.72
Enterprise Value/Gross Profit10.66
Enterprise Value/Ebitda-0.27
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

ONVO FAQ

What was Organovo Holdings’s price range in the past 12 months?
Organovo Holdings lowest stock price was $0.89 and its highest was $2.33 in the past 12 months.
    What is Organovo Holdings’s market cap?
    Currently, no data Available
    When is Organovo Holdings’s upcoming earnings report date?
    Organovo Holdings’s upcoming earnings report date is Aug 08, 2019 which is 1695 days ago.
      How were Organovo Holdings’s earnings last quarter?
      Organovo Holdings released its earnings results on May 22, 2019. The company reported -$22.951 earnings per share for the quarter, missing the consensus estimate of N/A by -$22.951.
        Is Organovo Holdings overvalued?
        According to Wall Street analysts Organovo Holdings’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Organovo Holdings pay dividends?
          Organovo Holdings does not currently pay dividends.
          What is Organovo Holdings’s EPS estimate?
          Organovo Holdings’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Organovo Holdings have?
          Organovo Holdings has 10,040,074 shares outstanding.
            What happened to Organovo Holdings’s price movement after its last earnings report?
            Organovo Holdings reported an EPS of -$22.951 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
              Which hedge fund is a major shareholder of Organovo Holdings?
              Among the largest hedge funds holding Organovo Holdings’s share is ARK Investment Management LLC. It holds Organovo Holdings’s shares valued at N/A.
                ---

                Company Description

                Organovo Holdings

                Organovo Holdings, Inc. engages in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Aptose Biosciences
                Accelerate Diagnostics
                Bioline RX Ltd Sponsored ADR
                Curis
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis